Everett Harris & Co’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$8K | – | 262 |
|
|
2022
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 268 |
|
|
2021
Q4 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 268 |
|
|
2021
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 266 |
|
|
2021
Q2 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 264 |
|
|
2021
Q1 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 258 |
|
|
2020
Q4 | $30K | Hold |
1,000
| – | – | ﹤0.01% | 252 |
|
|
2020
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 246 |
|
|
2020
Q2 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 238 |
|
|
2020
Q1 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 219 |
|
|
2019
Q4 | $31K | Hold |
1,000
| – | – | ﹤0.01% | 259 |
|
|
2019
Q3 | $33K | Hold |
1,000
| – | – | ﹤0.01% | 249 |
|
|
2019
Q2 | $32K | Hold |
1,000
| – | – | ﹤0.01% | 255 |
|
|
2019
Q1 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 247 |
|
|
2018
Q4 | $40K | Hold |
1,000
| – | – | ﹤0.01% | 238 |
|
|
2018
Q3 | $47K | Hold |
1,000
| – | – | ﹤0.01% | 251 |
|
|
2018
Q2 | $82K | Hold |
1,000
| – | – | ﹤0.01% | 245 |
|
|
2018
Q1 | $42K | Hold |
1,000
| – | – | ﹤0.01% | 243 |
|
|
2017
Q4 | $33K | Hold |
1,000
| – | – | ﹤0.01% | 241 |
|
|
2017
Q3 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 239 |
|
|
2017
Q2 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 235 |
|
|
2017
Q1 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 236 |
|
|
2016
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 230 |
|
|
2016
Q3 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 230 |
|
|
2016
Q2 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 236 |
|
|
2016
Q1 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 243 |
|
|
2015
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 236 |
|
|
2015
Q3 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 236 |
|
|
2015
Q2 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 240 |
|
|
2015
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 238 |
|
|
2014
Q4 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 237 |
|
|
2014
Q3 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 239 |
|
|
2014
Q2 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 229 |
|
|
2014
Q1 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 229 |
|
|
2013
Q4 | $17K | Buy |
+1,000
| New | +$16.9K | ﹤0.01% | 223 |
|
Other funds holding CASI
WSCM
WSC
IC
B
Everett Harris & Co's CASI Position: Q2 2022 in Review
Everett Harris & Co sold out of CASI Pharmaceuticals (CASI) in Q2 2022, closing a stake of 1,000 shares — an estimated $8K sold.
Everett Harris & Co first reported a position in CASI in Q4 2013 and held it in 34 quarters. The position peaked at $82K in Q2 2018. 24 funds tracked by Wall St. Rank hold CASI as of Q2 2022.
- Everett Harris & Co reported no remaining CASI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Everett Harris & Co sold 1,000 CASI Pharmaceuticals shares in Q2 2022, an estimated $8K.
- Everett Harris & Co first reported a position in CASI Pharmaceuticals in Q4 2013 and held it in 34 quarters.
- Everett Harris & Co's CASI Pharmaceuticals position peaked at $82K in Q2 2018.
- 24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2022.
Based on Everett Harris & Co's 13F filing for Q2 2022, filed 22 Jul 2022.